Eye Movement and Cognitive Dysfunction

Cognitive Dysfunction Clinical Trial

— EMCD  

Official title:

The Development of an Artificial Intelligence Platform for Screening and Referral of Cognitive Dysfunction

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04236375
• Other study ID #: Eye movement-cognitive decline
• Status: Not yet recruiting
• Start date: February 1, 2020
• Est. completion date: December 1, 2020

Study information

• Verified date: January 2020
• Source: Sun Yat-sen University
• Contact: Haotian Lin, M.D.,Ph.D
• Phone: 86-13802793086
• Email: gddlht[@]aliyun.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

There is association between eye movement disorder and cognitive dysfunction. Therefore, utilizing eye movement and screening for cognitive dysfunction is feasible. In the present study, we will develop an artificial intelligence platform to screening for cognitive dysfunction by inspecting the function of eye movement. Futher more, based on the screening results, the platform will offer referral suggestions.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 700
• Est. completion date: December 1, 2020
• Est. primary completion date: August 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 45 Years and older

Eligibility

Inclusion Criteria:

• ?Subjects who are diagnosed as mild cognitive decline, Alzheimer's disease, Vascular dementia, Lewy body dementia, Frontotemporal dementia, other dementia and normal by neurologist.

• ?Subjects who can cooperate with the inspection.

• ?Subjects who agree to participate in the study and sign the consent form

Exclusion Criteria:

• ?Subjects who cannot do the inspection.

• ?Subjects who suffer from diseases that compromise the inspection.

Related Conditions & MeSH terms

• Cognitive Dysfunction
• Eye Movement Disorder
• Movement Disorders
• Ocular Motility Disorders

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Sun Yat-sen University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Area under the curve	AUC values for predicting whether subject has cognitive impairment or not	up to 1 month
Secondary	Accuracy, true positive rate, and true negetive rate	The performance of this artificial platform	up to 1 month